Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding

Research and Practice in Thrombosis and Haemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles